Mustang Bio, Inc. (MBIO)
0.4711
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
Mustang Bio Net Income (Quarterly) : -1.072M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.072M |
| March 31, 2026 | -0.955M |
| December 31, 2025 | -0.538M |
| September 30, 2025 | -0.468M |
| June 30, 2025 | -0.762M |
| March 31, 2025 | -0.153M |
| December 31, 2024 | -0.952M |
| September 30, 2024 | -1.41M |
| June 30, 2024 | -8.199M |
| March 31, 2024 | -5.191M |
| December 31, 2023 | -8.616M |
| September 30, 2023 | -10.06M |
| June 30, 2023 | -16.24M |
| March 31, 2023 | -16.69M |
| December 31, 2022 | -19.63M |
| September 30, 2022 | -19.00M |
| June 30, 2022 | -19.10M |
| March 31, 2022 | -19.80M |
| December 31, 2021 | -20.05M |
| September 30, 2021 | -17.00M |
| June 30, 2021 | -14.36M |
| Date | Value |
|---|---|
| March 31, 2021 | -14.96M |
| December 31, 2020 | -20.61M |
| September 30, 2020 | -12.95M |
| June 30, 2020 | -14.60M |
| March 31, 2020 | -11.86M |
| December 31, 2019 | -16.21M |
| September 30, 2019 | -10.17M |
| June 30, 2019 | -10.40M |
| March 31, 2019 | -9.613M |
| December 31, 2018 | -11.77M |
| September 30, 2018 | -7.518M |
| June 30, 2018 | -5.093M |
| March 31, 2018 | -6.281M |
| December 31, 2017 | -15.60M |
| September 30, 2017 | -6.94M |
| June 30, 2017 | -5.529M |
| March 31, 2017 | -3.218M |
| December 31, 2016 | -8.748M |
| September 30, 2016 | -1.87M |
| June 30, 2016 | -1.133M |
| March 31, 2016 | -0.903M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
| Biogen, Inc. | 97.50M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 1.072M |
| EPS Diluted (Quarterly) | -0.1592 |
| Enterprise Value | -11.58M |
| Earnings Yield | -95.48% |
| Normalized Earnings Yield | -95.48 |